详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Performance of [18F]FDG PET/CT versus FAPI PET/CT for lung cancer assessment: a systematic review and meta-analysis

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Southwest Medical University, Luzhou, Sichuan, China [2]Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China [3]Department of Hematology, The Afliated Hospital of Southwest Medical University, Luzhou, Sichuan, China [4]Department of Nuclear Medicine, The Afliated Hospital of Southwest Medical University, Luzhou, Sichuan, China [5]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China [6]Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China [7]Chengdu Sport University, Chengdu, Sichuan, China [8]Department of Radiology, The Afliated Hospital of Southwest Medical University, No.25, Taiping St, Luzhou 646000, Sichuan, China

出处：

DOI：

ISSN：

关键词： Meta-analysis FAPI PET Lung cancer

摘要：

This article aims to compare the diagnostic performance of 18-fluorodeoxyglucose ([18F]FDG) PET/CT and fibroblast activating protein inhibitor (FAPI) PET/CT in the assessment of primary tumors, lymph nodes, and distant metastases in lung cancer patients.A systematic search was conducted on the Cochrane Library, Embase, and PubMed/MEDLINE databases from inception until November 1, 2022. Included studies assessed the use of FAPI PET/CT and [18F]FDG PET/CT in patients with lung cancer. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was used to evaluate the risk of bias. A random variable model was used to analyze the diagnostic tests of the two imaging modalities.The sensitivity of FAPI PET/CT in detecting primary lung cancer lesions was 0.98 (95% CI: 0.88-1.00), while the sensitivity of [18F]FDG PET/CT was 0.99 (95% CI: 0.74-1.00). For the detection of metastatic lesions (lymph node metastases and distant metastases), FAPI PET/CT had a sensitivity of 0.99 (95% CI: 0.90-1.00), while the sensitivity of [18F]FDG PET/CT was 0.77 (95% CI: 0.66-0.85). However, the specificity of the two imaging modalities could not be assessed due to the lack of sufficient information on pertinent true negatives.In the diagnosis of metastatic lung cancer lesions, FAPI PET/CT demonstrated a higher sensitivity compared to [18F]FDG PET/CT. Therefore, FAPI PET/CT may be considered an alternative imaging modality for the assessment of primary lung cancer tumors, lymph node metastases, and distant metastases.FAPI may be an alternative to [18F]FDG in the assessment of primary lung cancer tumors, lymph node metastases, and distant metastases, which plays a very important role in treatment.• This article is to compare the performance of [18F]FDG PET/CT with FAPI PET/CT in the assessment of primary tumors, lymph nodes, and distant metastases in lung cancer. • However, FAPI PET/CT has a higher sensitivity for the diagnostic assessment of metastatic lung cancer lesions.© 2023. The Author(s), under exclusive licence to European Society of Radiology.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 2 区

医学

小类 | 2 区核医学

最新[2023]版：

大类 | 2 区

医学

小类 | 2 区核医学

第一作者：

第一作者机构： [1]Southwest Medical University, Luzhou, Sichuan, China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Performance of fibroblast activating protein inhibitor PET imaging for pancreatic neoplasms assessment: a systematic review and meta-analysis [2]68Ga]Ga-FAPI PET/CT in brain tumors: comparison with [18F]F-FDG PET/CT [3]Mesenteric Mesonephric Adenocarcinoma on 68 Ga-FAPI PET/CT [4]Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer [5]Performance of 18 F‑FAPI PET/CT in assessing glioblastoma before radiotherapy: a pilot study [6]Diffuse large B-cell lymphoma detected by Al F-18-NOTA-FAPI-04 PET/CT [7]A retrospective study of 68Ga-FAPI PET/CT in differentiating the nature of pulmonary lesions [8](AlF)-F-18-NOTA-FAPI-04 Outperforms F-18-FDG PET/CT in Identifying the Primary Lesion and Rare Metastases From Gastric Cancer [9]A pilot study of [68Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma [10]Hepatic Lesion of Mucosa-Associated Lymphoid Tissue Lymphoma Revealed by Al18F-NOTA-FAPI-04 PET/CT.